New tricks for an old fox: Impact of TGFb on the DNA damage response and genomic stability

Science Signaling

Volumn 7, Issue 341, 2014, Pages

  Barcellos Hoff, Mary Helen ^a   Cucinotta, Francis A ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE E3; ATM PROTEIN, HUMAN; SMAD2 PROTEIN, HUMAN; SMAD7 PROTEIN, HUMAN;

ANEUPLOIDY; CELL CYCLE CHECKPOINT; CELL SURVIVAL; CELLS; CENTROSOME; CLINICAL TRIAL (TOPIC); DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROBLAST; GENE AMPLIFICATION; GENOMIC INSTABILITY; GLIOMA; HUMAN; MOLECULAR RECOGNITION; MOLECULARLY TARGETED THERAPY; NONHUMAN; PROTEIN DEPLETION; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL PROLIFERATION; DNA STRAND BREAKAGE; GENETICS; GENOMICS; METABOLISM; MOUSE; PHOSPHORYLATION; SYSTEMS BIOLOGY; TUMOR CELL LINE;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA BREAKS; DNA DAMAGE; EPITHELIAL CELLS; FIBROBLASTS; GENE AMPLIFICATION; GENOMIC INSTABILITY; GENOMICS; HUMANS; MICE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD7 PROTEIN; SYSTEMS BIOLOGY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84907587150     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005474     Document Type: Review

References (79)

1. Y. Shi, J. Massagué, Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003).
2. R. Derynck, Y. E. Zhang, Smad-dependent and Smad-independent pathways in TGF-b family signalling. Nature 425, 577-584 (2003).
3. M.K. Lee, C. Pardoux, M. C. Hall, P. S. Lee, D.Warburton, J. Qing, S. M. Smith, R. Derynck, TGF-b activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26, 3957-3967 (2007).
4. Z. Feng, S. Jin, A. Zupnick, J. Hoh, E. de Stanchina, S. Lowe, C. Prives, A. J. Levine, p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25, 1-7 (2006).
5. J. Massagué, TGFb in Cancer. Cell 134, 215-230 (2008).
6. A. Moustakas, C. H. Heldin, Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98, 1512-1520 (2007).
7. M. Yamashita, K. Fatyol, C. Jin, X. Wang, Z. Liu, Y. E. Zhang, TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-b. Mol. Cell 31, 918-924 (2008).
8. K. A. Brown, J. A. Pietenpol, H. L. Moses, A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF-b signaling. J. Cell. Biochem. 101, 9-33 (2007).
9. A. C. Daly, R. A. Randall, C. S. Hill, Transforming growth factor b-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28, 6889-6902 (2008).
10. I. M. Liu, S. H. Schilling, K. A. Knouse, L. Choy, R. Derynck, X. F. Wang, TGFb-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFb switch. EMBO J. 28, 88-98 (2009).
11. Y. Inoue, T. Imamura, Regulation of TGF-b family signaling by E3 ubiquitin ligases. Cancer Sci. 99, 2107-2112 (2008).
12. P. Kavsak, R. K. Rasmussen, C. G. Causing, S. Bonni, H. Zhu, G. H. Thomsen, J. L. Wrana, Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFb receptor for degradation. Mol. Cell 6, 1365-1375 (2000).
13. T. Ebisawa, M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, T. Imamura, K. Miyazono, Smurf1 interacts with transforming growth factor-b type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477-12480 (2001).
14. R. Derynck, R. J. Akhurst, A. Balmain, TGF-b signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129 (2001).
15. M. Miyaki, T. Kuroki, Role of Smad4 (DPC4) inactivation in human cancer. Biochem. Biophys. Res. Commun. 306, 799-804 (2003).
16. K. E. Hoot, J. Lighthall, G. Han, S. L. Lu, A. Li, W. Ju, M. Kulesz-Martin, E. Bottinger, X. J.Wang, Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest. 118, 2722-2732 (2008).
17. T. Hamamoto, H. Beppu, H. Okada, M. Kawabata, T. Kitamura, K. Miyazono, M. Kato, Compound disruption of Smad2 accelerates malignant progression of intestinal tumors in Apc knockout mice. Cancer Res. 62, 5955-5961 (2002).
18. W. Xie, J. C. Mertens, D. J. Reiss, D. L. Rimm, R. L. Camp, B. G. Haffty, M. Reiss, Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: A tissue microarray study. Cancer Res. 62, 497-505 (2002).
19. R. J. Akhurst, TGF-b antagonists: Why suppress a tumor suppressor? J. Clin. Invest. 109, 1533-1536 (2002).
20. A. B. Glick, W. C. Weinberg, I. H. Wu, W. Quan, S. H. Yuspa, Transforming growth factor b1 suppresses genomic instability independent of a G1 arrest, p53, and Rb. Cancer Res. 56, 3645-3650 (1996).
21. C. A. Maxwell, M. C. Fleisch, S. V. Costes, A. C. Erickson, A. Boissière, R. Gupta, S. A. Ravani, B. Parvin, M. H. Barcellos-Hoff, Targeted and nontargeted effects of ionizing radiation that impact genomic instability. Cancer Res. 68, 8304-8311 (2008).
22. M. H. Barcellos-Hoff, Radiation-induced transforming growth factor b and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53, 3880-3886 (1993).
23. E. J. Ehrhart, P. Segarini, M. L. Tsang, A. G. Carroll, M. H. Barcellos-Hoff, Latent transforming growth factor-b1 activation in situ: Quantitative and functional evidence after low dose g-irradiation. FASEB J. 11, 991-1002 (1997).
24. J. Wang, H. Zheng, C. C. Sung, K. K. Richter, M. Hauer-Jensen, Cellular sources of transforming growth factor-b isoforms in early and chronic radiation enteropathy. Am. J. Pathol. 153, 1531-1540 (1998).
25. M. Hauer-Jensen, K. K. Richter, J. Wang, E. Abe, C. C. Sung, J. W. Hardin, Changes in transforming growth factor b1 gene expression and immunoreactivity levels during development of chronic radiation enteropathy. Radiat. Res. 150, 673-680 (1998).
26. K. A. Becker, S. Lu, E. S. Dickinson, K. A. Dunphy, L. Mathews, S. S. Schneider, D. J. Jerry, Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-b-dependent pathways. Oncogene 24, 6345-6353 (2005).
27. F. Milliat, A. François,M. Isoir, E. Deutsch, R. Tamarat, G. Tarlet, A. Atfi, P. Validire, J. Bourhis, J. C. Sabourin, M. Benderitter, Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: Implication in radiation-induced vascular damages. Am. J. Pathol. 169, 1484-1495 (2006).
28. G. Tabatabai, B. Frank, R. Möhle, M. Weller, W. Wick, Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-b-dependent HIF-1amediated induction of CXCL12. Brain 129, 2426-2435 (2006).
29. T. Kanamoto, U. Hellman, C. H. Heldin, S. Souchelnytskyi, Functional proteomics of transforming growth factor-b1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFb1-dependent regulation of DNA repair. EMBO J. 21, 1219-1230 (2002).
30. K. B. Ewan, R. L. Henshall-Powell, S. A. Ravani, M. J. Pajares, C. L. Arteaga, R. L.Warters, R. J. Akhurst, M. H. Barcellos-Hoff, Transforming growth factor-b1 mediates cellular response to DNA damage in situ. Cancer Res. 62, 5627-5631 (2002).
31. J. Kirshner,M. F. Jobling, M. J. Pajares, S. A. Ravani, A. Glick, M. Lavin, S. Koslov, Y. Shiloh, M. H. Barcellos-Hoff, Inhibition of transforming growth factor-b1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Res. 66, 10861-10869 (2006).
32. Y. Shiloh, Y. Ziv, The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14, 197-210 (2013).
33. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D. A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S. R. Patanjali, A. Simmons, G. A. Clines, A. Sartiel, R. A. Gatti, L. Chessa, O. Sanal, M. F. Lavin, N. G. Jaspers, A. M. Taylor, C. F. Arlett, T. Miki, S. M.Weissman, M. Lovett, F. S. Collins, Y. Shiloh, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753 (1995).
34. O. Fernandez-Capetillo, A. Celeste, A. Nussenzweig, Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2, 426-427 (2003).
35. L. H. Thompson, Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography. Mutat. Res. 751, 158-246 (2012).
36. A. Gupta, C. R. Hunt, S. Chakraborty, R. K. Pandita, J. Yordy, D. B. Ramnarain, N. Horikoshi, T. K. Pandita, Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat. Res. 181, 1-8 (2014).
37. A. A. Goodarzi, P. A. Jeggo, Irradiation induced foci (IRIF) as a biomarker for radiosensitivity. Mutat. Res. 736, 39-47 (2012).
38. I. Rappold, K. Iwabuchi, T.Date, J. Chen, Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153, 613-620 (2001).
39. A. Bhoumik, S. Takahashi,W. Breitweiser, Y. Shiloh, N. Jones, Z. Ronai, ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol. Cell 18, 577-587 (2005).
40. M. K. Whalen, S. K. Gurai, H. Zahed-Kargaran, J. M. Pluth, Specific ATM-mediated phosphorylation dependent on radiation quality. Radiat. Res. 170, 353-364 (2008).
41. S. Burma, B. P. Chen, M. Murphy, A. Kurimasa, D. J. Chen, ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276, 42462-42467 (2001).
42. E. M. Wiegman, M. A. Blaese, H. Loeffler, R. P. Coppes, H. P. Rodemann, TGFb- 1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFb-receptor I signalling. Radiother. Oncol. 83, 289-295 (2007).
43. L. Levy, C. S. Hill, Smad4 dependency defines two classes of transforming growth factor b (TGF-b) target genes and distinguishes TGF-b-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol. Cell. Biol. 25, 8108-8125 (2005).
44. G. J. Inman, F. J. Nicolás, C. S. Hill, Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-b receptor activity. Mol. Cell 10, 283-294 (2002).
45. A. Nakao, M. Afrakhte, A. Morén, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, P. ten Dijke, Identification of Smad7, a TGFb-inducible antagonist of TGF-b signalling. Nature 389, 631-635 (1997).
46. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y. Y. Xu, B.W. Grinnell, M. A. Richardson, J. N. Topper, M. A. Gimbrone Jr., J. L.Wrana, D. Falb, The MAD-related protein Smad7 associates with the TGFb receptor and functions as an antagonist of TGFb signaling. Cell 89, 1165-1173 (1997).
47. M. Simonsson, C. H. Heldin, J. Ericsson, E. Grönroos, The balance between acetylation and deacetylation controls Smad7 stability. J. Biol. Chem. 280, 21797-21803 (2005).
48. S. Kume, M. Haneda, K. Kanasaki, T. Sugimoto, S.-i. Araki, K. Isshiki, M. Isono, T. Uzu, L. Guarente, A. Kashiwagi, D. Koya, SIRT1 inhibits transforming growth factor b-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J. Biol. Chem. 282, 151-158 (2007).
49. S. Zhang, M. Ekman, N. Thakur, S. Bu, P. Davoodpour, S. Grimsby, S. Tagami, C. H. Heldin, M. Landström, TGFb1-induced activation of ATM and p53 mediates apoptosis in a Smad7-dependent manner. Cell Cycle 5, 2787-2795 (2006).
50. S. V. Costes, A. Boissière, S. A. Ravani, R. Romano, B. Parvin, M. H. Barcellos-Hoff, Imaging features that discriminate between high- and low-LET radiation-induced foci in human fibroblasts. Radiat. Res. 165, 505-515 (2006).
51. S. V.Costes, A. Ponomarev, J. L. Chen, D. Nguyen, F. A. Cucinotta,M. H. Barcellos-Hoff, Image-based modeling reveals dynamic redistribution of DNA damage into nuclear subdomains. PLOS Comput. Biol. 3, e155 (2007).
52. F. A. Cucinotta, J. M. Pluth, J. A. Anderson, J. V. Harper, P. O'Neill, Biochemical kinetics model of DSB repair and induction of g-H2AX foci by non-homologous end joining. Radiat. Res. 169, 214-222 (2008).
53. M. Wang, J. Saha, M. Hada, J. A. Anderson, J. M. Pluth, P. O'Neill, F. A. Cucinotta, Novel Smad proteins localize to IR-induced double-strand breaks: Interplay between TGFb and ATM pathways. Nucleic Acids Res. 41, 933-942 (2013).
54. X. Shi, F. Chen, J. Yu, Y. Xu, S. Zhang, Y. G. Chen, X. Fang, Study of interaction between Smad7 and DNA by single-molecule force spectroscopy. Biochem. Biophys. Res. Commun. 377, 1284-1287 (2008).
55. M. Cordenonsi, S. Dupont, S. Maretto, A. Insinga, C. Imbriano, S. Piccolo, Links between tumor suppressors: p53 is required for TGF-b gene responses by cooperating with Smads. Cell 113, 301-314 (2003).
56. R. Elston, G. J. Inman, Crosstalk between p53 and TGF-b Signalling. J. Signal Transduct. 2012, 294097 (2012).
57. A. Dubrovska, T. Kanamoto, M. Lomnytska, C. H. Heldin, N. Volodko, S. Souchelnytskyi, TGFb1/Smad3 counteracts BRCA1-dependent repair of DNA damage. Oncogene 24, 2289-2297 (2005).
58. S. Park, J. Kang, S. Kim, H. Kim, S. Hong, Y. Lee, S. J. Kim, Smad7 enhances ATM activity by facilitating the interaction between ATM and Mre11-Rad50-Nbs1 complex in DNA double-strand break repair. Cell. Mol. Life Sci. 10.1007/s00018-014-1687-z (2014).
59. M. Wang, J. Saha, F. A. Cucinotta, Smad7 foci are present in micronuclei induced by heavy particle radiation. Mutat. Res. 756, 108-114 (2013).
60. J. Kleeff, T. Ishiwata, H. Maruyama, H. Friess, P. Truong, M. W. Büchler, D. Falb, M. Korc, The TGF-b signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18, 5363-5372 (1999).
61. X. Liu, J. Lee, M. Cooley, E. Bhogte, S. Hartley, A. Glick, Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res. 63, 7760-7768 (2003).
62. S. Du, M. H. Barcellos-Hoff, Tumors as organs: Biologically augmenting radiation therapy by inhibiting transforming growth factor b actions in carcinomas. Sem. Radiat. Oncol. 23, 242-251 (2013).
63. S. F. Bouquet, A. Pal, K. A. Pilones, S. Demaria, B. Hann, R. J. Akhurst, J. S. Babb, S. M. Lonning, J. K. DeWyngaert, S. Formenti, M. H. Barcellos-Hoff, TGFb1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin. Cancer Res. 17, 6754-6765 (2011).
64. M. E. Hardee, A. E. Marciscano, C. M. Medina-Ramirez, D. Zagzag, A. Narayana, S. M. Lonning, M. H. Barcellos-Hoff, Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-b. Cancer Res. 72, 4119-4129 (2012).
65. J. Banerjee, R. Mishra, X. Li, R. S. Jackson II, A. Sharma, N. A. Bhowmick, A reciprocal role of prostate cancer on stromal DNA damage. Oncogene 10.1038/onc.2013.431 (2013).
66. Z. Mengxian, S. Kleber, M. Röehrich, C. Timke, N. Han, J. Tuettenberg, A. Martin-Villalba, J. Debus, P. Peschke, U. Wirkner, M. M. Lahn, P. E. Huber, Blockade of TGF-b signaling by the TGFbR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Cancer Res. 71, 7155-7167 (2011).
67. W. J. Kil, D. Cerna, W. E. Burgan, K. Beam, D. Carter, P. S. Steeg, P. J. Tofilon, K. Camphausen, In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide. Clin. Cancer Res. 14, 931-938 (2008).
68. M. Zhang, T. W. Herion, C. Timke, N. Han, K. Hauser, K. J.Weber, P. Peschke, U.Wirkner, M. Lahn, P. E. Huber, Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-b receptor I kinase inhibitor LY2109761. Neoplasia 13, 537-549 (2011).
69. L. H. Hartwell, J. J. Hopfield, S. Leibler, A. W. Murray, From molecular to modular cell biology. Nature 402, C47-C52 (1999).
70. D. Del Vecchio, A. J. Ninfa, E. D. Sontag, Modular cell biology: Retroactivity and insulation. Mol. Syst. Biol. 4, 161 (2008).
71. W. L. Lingle, S. L. Barrett, V. C. Negron, A. B. D'Assoro, K. Boeneman, W. M. Liu, C. M. Whitehead, C. Reynolds, J. L. Salisbury, Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. U.S.A. 99, 1978-1983 (2002).
72. J. Bartkova, Z. Horejsí, K. Koed, A. Krämer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J. M. Nesland, C. Lukas, T. Ørntoft, J. Lukas, J. Bartek, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
73. V. G. Kaklamani, L. Baddi, J. Liu, D. Rosman, S. Phukan, C. Bradley, C. Hegarty, B.McDaniel, A. Rademaker, C. Oddoux, H. Ostrer, L. S. Michel, H. Huang, Y.Chen, H. Ahsan, K. Offit, B. Pasche, Combined genetic assessment of transforming growth factor-b signaling pathway variants may predict breast cancer risk. Cancer Res. 65, 3454-3461 (2005).
74. B. Pasche, T. J. Knobloch, Y. Bian, J. Liu, S. Phukan, D. Rosman, V. Kaklamani, L. Baddi, F. S. Siddiqui, W. Frankel, T. W. Prior, D. E. Schuller, A. Agrawal, J. Lang, M. E. Dolan, E. E. Vokes, W. S. Lane, C. C. Huang, T. Caldes, A. Di Cristofano, H. Hampel, I. Nilsson, G. von Heijne, R. Fodde, V. V. Murty, A. de la Chapelle, C. M. Weghorst, Somatic acquisition and signaling of TGFBR1, 6A in cancer. JAMA 294, 1634-1646 (2005).
75. P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S. J. Kim, M. A. Eckhaus, T. Ried, R. E. Gress, Transforming growth factor-b pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. Cancer Res. 64, 6524-6529 (2004).
76. B. Tang, E. P. Böttinger, S. B. Jakowlew, K. M. Bagnall, J. Mariano, M. R. Anver, J. J. Letterio, L. M. Wakefield, Transforming growth factor-b1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4, 802-807 (1998).
77. E. Forrester, A. Chytil, B. Bierie, M. Aakre, A. E. Gorska, A. R. Sharif-Afshar,W. J. Muller, H. L. Moses, Effect of conditional knockout of the type II TGF-b receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65, 2296-2302 (2005).
78. A. Glick, N. Popescu, V. Alexander, H. Ueno, E. Bottinger, S. H. Yuspa, Defects in transforming growth factor-b signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 96, 14949-14954 (1999).
79. K. Chin, C. O. de Solorzano, D. Knowles, A. Jones,W. Chou, E. G. Rodriguez,W. L. Kuo, B. M. Ljung, K. Chew, K. Myambo, M. Miranda, S. Krig, J. Garbe, M. Stampfer, P. Yaswen, J.W. Gray, S. J. Lockett, In situ analyses of genome instability in breast cancer. Nat. Genet. 36, 984-988 (2004).